Literature DB >> 33569074

A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson's Disease Dementia.

Dinesh Saini1, Adreesh Mukherjee1, Arijit Roy1, Atanu Biswas1.   

Abstract

BACKGROUND: Executive dysfunction is the common thread between pure cortical dementia like the behavioral variant of frontotemporal dementia (bvFTD) and subcortical dementia like Parkinson's disease dementia (PDD). Although there are clinical and cognitive features to differentiate cortical and subcortical dementia, the behavioral symptoms differentiating these 2 conditions are still not well known.
OBJECTIVE: To evaluate the behavioral profile of bvFTD and PDD and compare them to find out which behavioral symptoms can differentiate between the two.
METHODS: Twenty consecutive patients with bvFTD (>1 year after diagnosis) and 20 PDD patients were recruited according to standard diagnostic criteria. Behavioral symptoms were collected from the reliable caregiver by means of a set of questionnaires and then compared between the 2 groups.
RESULTS: bvFTD patients had more severe disease and more behavioral symptoms than PDD. bvFTD patients were different from PDD patients due to their significantly greater: loss of basic emotion (p < 0.001, odds ratio [OR] 44.33), loss of awareness of pain (p < 0.001, OR 44.33), disinhibition (p < 0.001, OR 35.29), utilization phenomenon (p = 0.008, OR 22.78), loss of taste discrimination (p < 0.001, OR 17), neglect of hygiene (p = 0.001, OR 13.22), loss of embarrassment (p = 0.003, OR 10.52), wandering (p = 0.004, OR 9.33), pacing (p = 0.014, OR 9), selfishness (p = 0.014, OR 9), increased smoking (p = 0.014, OR 9), increased alcohol consumption (p = 0.031, OR 7.36), social avoidance (p = 0.012, OR 6.93), mutism (p = 0.041, OR 5.67), and failure to recognize objects (p = 0.027, OR 4.33). The bvFTD patients were also significantly less suspicious (p = 0.001, OR 0.0295), less inclined to have a false belief that people were in their home (p = 0.014, OR 0.11) and had fewer visual illusions/hallucinations (p = 0.004, OR 0.107) than PDD patients.
CONCLUSION: Behavioral symptoms are helpful to distinguish bvFTD from PDD, and thus also cortical dementia with frontal-lobe dysfunction from subcortical dementia.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Behavioral symptoms; Behavioral variant of frontotemporal dementia; Cortical dementia; Parkinson's disease dementia; Subcortical dementia

Year:  2020        PMID: 33569074      PMCID: PMC7841718          DOI: 10.1159/000512042

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Dis Extra        ISSN: 1664-5464


Introduction

The frontal lobe plays a crucial role in human behavior. Some of the most striking neurobehavioral syndromes are coupled with frontal-lobe dysfunction. Cummings [1] described 3 clinical syndromes that involve frontal-lobe circuitry: (a) apathy and akinesia resulting from damage to the mesial frontal or anterior cingulate pathway, (b) disinhibition, emotional dysregulation, and distractibility resulting from damage to the orbitofrontal cortex, and (c) deficits in executive function and motor programming due to damage to the dorsolateral prefrontal cortex. Among degenerative neurological disorders, the behavioral variant of frontotemporal dementia (bvFTD) presents with behavioral alterations very early in the disease course, even before cognitive dysfunction becomes evident. As the mesial frontal lobe is connected to the hippocampus and the orbital frontal lobe is connected to the inferior and superior temporal lobes, cortical dementias like Alzheimer's disease (AD) also demonstrate marked behavioral changes [2]. The prefrontal cortex also has extensive connections with subcortical structures such as the basal ganglia and thalamus, and disturbance of these frontosubcortical circuits also results in abnormal behaviors [1, 3]. Thus, behavioral abnormalities occur both in cortical dementia (bvFTD, AD, etc.) and subcortical dementia (Huntington's disease, Parkinson's disease dementia [PDD], and vascular dementia [VaD]) [4]. Common behavioral abnormalities observed in PDD include depression, anxiety, and apathy. PDD patients may also have excessive daytime sleepiness, visual hallucinations, delusions, paranoia, and confusion [5]. The characteristics of bvFTD are early and profound alterations in personality, social conduct, and behavior. However, these symptoms are not specific to this disease. There is a significant overlap of the symptoms of bvFTD and psychiatric diseases such as bipolar disorder and schizophrenia [6]. Degeneration of the dorsolateral prefrontal cortex also leads to disturbed executive function in patients with bvFTD. The cognitive disturbance of subcortical dementia manifests as impairment of executive function, impaired attention, reduced speed of information processing, and retrieval defect in memory tasks that improve with cueing. Patients of subcortical dementia often exhibit frontal behavioral features like that of bvFTD, which can create diagnostic difficulties [7]. Clinicians rely upon the cognitive profile and presence of additional motor features and sphincter disturbance to distinguish subcortical from cortical dementia. To clinically differentiate between various dementias, efforts have been made to investigate the behavioral and psychiatric symptoms of these patients [8, 9, 10]. However, only a few studies have attempted to explore the behavioral profile to differentiate cortical and subcortical dementia [2]. We hypothesized that core frontal-lobe behaviors, such as impaired social cognition, disinhibition, alteration of feeding, sexual behavior and sensory perceptions, environmental dependency, etc. are relatively uncommon in subcortical dementia, and can thus be used to clinically differentiate cortical and subcortical dementia. We used a questionnaire prepared by Bathgate et al. [11] to capture the behavior of patients. This questionnaire was developed with the primary aim of determining the discriminating value of behavioral characteristics in differentiating bvFTD from 2 common forms of dementia, AD, and subcortical vascular dementia. To differentiate FTD from AD, informant-based behavioral interviews were also developed by Bozeat et al. [12], and Ikeda et al. [13]. However, Bathgate et al. [11] demonstrated that changes in emotions and insight, selfishness, disinhibition, personal neglect, gluttony and sweet food preference, wandering, stereotypies, loss of sensitivity to pain, echolalia, and mutism were more characteristic of bvFTD, and differentiated most bvFTD from AD and vascular dementia. The Frontal Systems Behavior Scale (FrSBe) is another questionnaire which measures behavior associated with frontal subcortical deficits, but it tests only 3 items, apathy, disinhibition, and executive dysfunction [2]. We planned to evaluate the behavioral profiles of bvFTD as representative of cortical dementia, and PDD as representative of subcortical dementia, and compare them to find out which behavioral symptoms differentiate cortical and subcortical dementia.

Methods

This was a questionnaire-based, observational, comparative study conducted between March 2015 and October 2016. A purposive sampling technique was employed for the recruitment of patients from the Cognitive and Movement Disorders Clinic (MDC) of our institute. We selected patients with probable bvFTD, diagnosed according to the international consensus criteria for bvFTD [6]. Patients with bvFTD of >1 year's duration and regularly attending follow-up were included in the study. Parkinsonian patients who had regularly attended follow-up at the MDC for >5 years and had received a primary diagnosis of idiopathic Parkinson's disease (IPD) were recruited. At the point of their recruitment, these patients had cognitive dysfunction and fulfilled the clinical diagnostic criteria for PDD [14]. We excluded (a) patients and caregivers who were not willing to participate in the study, (b) patients with overlapping features of both degenerative and vascular dementia, (c) patients with such severe dementia that they could not be assessed, and (d) patients with incomplete clinical evaluation and brain imaging data. A detailed history was obtained from each patient/a reliable caregiver, and neurological examinations and cognitive functions assessment were conducted. Their attention was tested using the continuous performance task/test, digit span test, and serial subtraction test. Memory was tested with the verbal learning test as per the Kolkata Cognitive Screening Battery [15]. For language, we used the Bengali version of the Western Aphasia Battery [16]. Visuospatial domain was tested using the letter cancellation task and line bisection test, while visuoperceptual testing was done via dot-counting, fragmented letters, and progressive silhouettes. Frontal-lobe function testing was done using the Frontal Assessment Battery (FAB) [17]. All the above tools and tests were validated for the Bengali language, and we have used them in previous studies as well [18, 19]. All patient underwent detailed lab investigations, including complete blood count, erythrocyte sedimentation rate, blood biochemical tests like the thyroid function test, levels of serum Vitamin B12, fasting and postprandial blood glucose, and glycosylated hemoglobin. Lipid profile was obtained, and tests of liver and renal function as well as magnetic resonance imaging (MRI) of the brain were conducted. Behavioral symptoms were collected from a reliable caregiver via a set of questionnaires developed by Bathgate et al. [11]. In this checklist, various behaviors were subcategorized into 7 major categories − affect and social, sensory behaviors, eating and vegetative behaviors, repetitive and-compulsive ritual behaviors, environmental dependency, cognitively mediated behaviors, and behaviors related to psychosis. We used the Bengali translated version. It was emphasized that a “symptom” should reveal a remarkable change from the patient's premorbid condition and not a longstanding trait. We ensured that each symptom being assessed was understood by the caregivers. The response to each question was recorded as the absence or presence of symptoms. Interviews were conducted by a single interviewer.

Statistical Analysis

For statistical analysis, data were entered in a Microsoft Excel spreadsheet and then analyzed by SPSS v24.0 (SPSS Inc., Chicago, IL, USA) and GraphPad Prism v5. We used descriptive statistics for analyzing the baseline demographics, Bengali Mental Status Examination (BMSE), Clinical Dementia Rating (CDR), and FAB scores. Data were summarized as mean and SD for continuous variables and n (%) for categorical variables. The various domains of behavioral symptoms in the bvFTD and PDD patients were compared by χ2/Fisher's exact test. For the comparison of continuous variables between groups, the Mann-Whitney U test was performed. A p value <0.05 was considered significant.

Results

Twenty bvFTD patients and 20 PDD were recruited for the study. Demographic profiles of our patients are given in Table 1. The bvFTD patients were younger than the PDD patients, but the difference was not statistically significant. There was male predominance in both groups. The mean duration of dementia at presentation was 3.85 (±1.57) years in the bvFTD group, i.e., comparable to the duration of dementia in the PDD group (4.3 ± 2.25 years). There was also no significant difference in years of education between bvFTD (6.35 ± 5.16) and PDD (7.35 ± 4.93) patients. bvFTD patients were cognitively more impaired than PDD patients.
Table 1

Demographic and cognitive characteristics of bvFTD and PDD

bvFTDPDDp value
N2020
Age, years56.60±10.2662.25±7.260.052
Gender
 Male, n15130.49
 Female, n57
Duration of illness, years3.85±1.574.3±2.250.718
Years of education6.35±5.167.35±4.930.535
BMSE score9.05±5.3720.60±5.630.0001*
FAB score1.95±2.438.25±6.020.0001*
CDR1.29±0.370.89±0.350.0001*

Values express mean ± SD, unless otherwise indicated. Asterisks denote significance. bvFTD, behavioral variant of frontotemporal dementia; PDD, Parkinson's disease dementia; BMSE, Bengali Mental Status Examination; FAB, Frontal Assessment Battery; CDR, Clinical Dementia Rating.

bvFTD patients had more affected behavioral domains than PDD patients. While all (100%) bvFTD patients had ≥3 domains of behavioral symptoms, only 25% of PDD patients had <3 affected domains (p = 0.047). Table 2 shows the distribution of domains affected in the 2 groups of patients. Overall, all major behavioral domains were more commonly observed in bvFTD than in PDD, except for neuropsychiatric behavior (Table 3).
Table 2

Frequency of behavioral domains affected in bvFTD and PDD

Type of dementiaNumber of behavioral domains affectedp value
<3≥3
bvFTD, n (%)020 (100)0.047
PDD, n (%)5 (25)15 (75)

bvFTD, behavioral variant of frontotemporal dementia; PDD, Parkinson's disease dementia.

Table 3

Comparison of behavioral symptoms in bvFTD and PDD

bvFTD, n (%)PDD, n (%)p valueOR (95% CI)
A. Affect and social behavior
Loss of basic emotion19 (95.0)6 (30.0)<0.001*44.33 (4.78–410.94)
Exaggerated emotional display5 (25.0)3 (15.0)0.694
Loss of embarrassment13 (65.0)3 (15.0)0.003*10.52 (2.27–48.76)
Irritability14 (70.0)11 (55.0)0.327
Aggression11 (55.0)5 (25.0)0.053
Loss of insight19 (95.0)16 (80.0)0.342
Excessive worrying12 (60.0)8 (40.0)0.206
Selfishness10 (50.0)2 (10.0)0.014*9.00 (1.64–49.45)
Disinhibition19 (95.0)7 (35.0)<0.001*35.29 (3.87–321.93)
Social avoidance17 (85.0)9 (45.0)0.012*6.93 (1.53–31.38)
Seeks out social contact4 (20.0)8 (40.0)0.301
Neglect of hygiene17 (85.0)6 (30.0)0.001*13.22 (2.79–62.67)
Loss of interest18 (90.0)13 (65.0)0.127

B. Sensory behavior
Loss of awareness of pain14 (70.0)1 (5.0)<0.001*44.33 (4.78–410.94)
Loss of smell11 (55.0)12 (60.0)0.749
Exaggerated sensory response6 (30.0)4 (20.0)0.716
Exaggerated heat/cold response7 (35.0)5 (25.0)0.490

C. Eating and vegetative behaviors
Preference for sweet foods6 (30.0)4 (20.0)0.716
Preference for savory foods1 (5.0)1 (5.0)1.000
Food fads2 (10.0)3 (15.0)1.000
Loss of discrimination17 (85.0)5 (25.0)<0.001*17.00 (3.46–83.44)
Overeats8 (40.0)2 (10.0)0.065
Eats continually if food is present6 (30.0)2 (10.0)0.235
Steals food from others' plates5 (25.0)2 (10.0)0.407
Seeks out food6 (30.0)2 (10.0)0.235
Crams food5 (25.0)2 (10.0)0.407
Increased alcohol consumption9 (45.0)2 (10.0)0.031*7.36 (1.34–40.55)
Increased smoking10 (50.0)2 (10.0)0.014*9.00 (1.64–49.45)
Oral exploration of objects5 (25.0)1 (5.0)0.182
Wandering14 (70.0)4 (20.0)0.004*9.33 (2.18–39.96)
Pacing10 (50.0)2 (10.0)0.014*9.00 (1.64–49.45)
Hyposexuality10 (50.0)6 (30.0)0.197
Hypersexuality4 (20.0)2 (10.0)0.661
Hypersomnia6 (30.0)5 (25.0)0.723
Hyposomnia10 (50.0)10 (50.0)1.000

D. Repetitive and compulsive behaviors
Simple motor stereotypies7 (35.0)2 (10.0)0.127
Complex motor routines3 (15.0)00.231
Paces fixed route4 (20.0)1 (5.0)0.342
Verbal stereotypies/perseverations5 (25.0)3 (15.0)0.695
Repetitive themes1 (5.0)01.000
Counts objects1 (5.0)2 (10.0)1.000
Aligns objects2 (10.0)00.487
Adherence to daily routine3 (15.0)1 (5.0)0.605
Overconcern with cleanliness01 (5.0)1.000
Clock-watching4 (20.0)5 (25.0)1.000
Excessive checking2 (10.0)1 (5.0)1.000
Excessive attention to detail2 (10.0)3 (15.0)1.000
Upset if routine disrupted3 (15.0)3 (15.0)1.000
Needs to do things immediately2 (10.0)2 (10.0)1.000
Unusual toileting routines8 (40.0)9 (45.0)0.749
Superstitious rituals01 (5.0)1.000

E. Environmental dependency-related behaviors
Hoarding2 (10.0)2 (10.0)1.000
Touches or handles objects6 (30.0)2 (10.0)0.235
Echolalia4 (20.0)00.106
Echopraxia2 (10.0)00.487
Utilization phenomenaReads aloud notices7 (35.0)2 (10.0)02 (10.0)0.008*1.00022.78 (1.2–432.61)

F. Cognitively mediated behaviors
Mislays objects13 (65.0)8 (40.0)0.113
Lost in familiar surroundings9 (45.0)7 (35.0)0.519
Disorientation in own home11 (55.0)8 (40.0)0.342
Fails to recognize objects13 (65.0)6 (30.0)0.027*4.33 (1.15–16.32)
Difficulty locating objects12 (60.0)10 (50.0)0.525
Uses wrong words9 (45.0)5 (25.0)0.185
Mutism10 (50.0)3 (15.0)0.041*5.67 (1.25–25.61)

G. Psychosis-related behaviors (hallucinations and delusions)
Suspiciousness09 (45.0)0.001*0.0295 (0.002–0.56)
Delusions of theft4 (20.0)9 (45.0)0.176
False belief that people are in their home2 (10.0)10 (50.0)0.014*0.11 (0.02–0.61)
Misidentification phenomena5 (25.0)11 (55.0)0.053
Visual illusions/hallucinations4 (20.0)14 (70.0)0.004*0.107 (0.025–0.46)
Auditory illusions/hallucinations2 (10.0)3 (15.0)1.000

Asterisks denote significance. OR, odds ratio; CI, confidence interval; bvFTD, behavioral variant of frontotemporal dementia; PDD, Parkinson's disease dementia.

Abnormal affect and social behavior were observed in all bvFTD patients and in 80% of the PDD patients. Regarding social behavior, the following subdomains were significantly more common in bvFTD than in PDD: loss of basic emotion (p < 0.001, odds ratio [OR] 44.33), disinhibition (p < 0.001, OR 35.29), neglect of hygiene (p = 0.001, OR 13.22), loss of embarrassment (p = 0.003, OR 10.52), social avoidance (p = 0.012, OR 6.93), and selfishness (p = 0.014, OR 9). Although most other subdomains were also observed more in bvFTD than in PDD, the differences were not statistically significant. Abnormal sensory behavior was also more common in bvFTD than PDD. Loss of the sensation of pain was significantly more common in bvFTD (p < 0.001, OR 44.33). Loss of smell as well as exaggerated heat and cold responses were observed to be almost similar in the 2 groups. Eating and vegetative behavior were significantly more abnormal in patients with bvFTD (85%) than in those with PDD (45%). The loss of taste discrimination (p < 0.001, OR 17), increased consumption of alcohol (p = 0.031, OR 7.36), and increased smoking (p = 0.014, OR 9) were significantly more evident in bvFTD. Although not statistically significant, overeating was reported more frequently in bvFTD (p = 0.065). Of the vegetative behaviors, wandering (p = 0.004, OR 9.33) and pacing (p = 0.014, OR 9) were found to be significantly more common in bvFTD, while other behaviors were common but did not attain statistical significance. In the repetitive and compulsive behavior domain, no subdomain was significantly more common in either group. However, simple and complex motor stereotypies, and verbal stereotypies or perseverations were reported more commonly in bvFTD. While 40% of bvFTD patients had environmental dependency, only 15% of PDD patients showed similar behavior. Utilization behavior was observed in 35% of the bvFTD but there was none in the PDD group (p = 0.008, OR 22.78). Although the differences did not attain significance, echolalia (20%) and echopraxia (10%) were observed only in bvFTD patients. Cognitively mediated behavior was also more common in bvFTD (70%) than in PDD (60%). Failure to recognize objects (p = 0.027, OR 4.33) and mutism (p = 0.041, OR 5.67) were significantly more common in bvFTD. Of all these behavioral symptoms, neuropsychiatric behavior was more commonly observed in PDD (80%) than in bvFTD (50%). Suspiciousness (p = 0.001, OR 0.0295), the false belief that people were in their home (p = 0.014, OR 0.11) and visual illusions/hallucinations (p = 0.004, OR 0.107) were significantly less common in bvFTD than in PDD. Although not statistically significant, the misidentification phenomenon (p = 0.053) and delusions of theft (p = 0.176) were more common in PDD. We analyzed cognitive performance in relation to behavioral symptoms of bvFTD and PDD patients. In the bvFTD group, FAB score was significantly lower in patients with neglect of hygiene (p = 0.04), loss of interest (p = 0.021), and loss of smell (p = 0.001), but higher in those who got upset if their routine was disrupted (p = 0.04) and who had verbal stereotypies/ perseverations (p = 0.015). Patients with hypersomnia had a higher BMSE score (p = 0.026). Although not statistically significant, patients with hyposomnia had lower BMSE and FAB scores. In the PDD group (Table 4), FAB scores were significantly lower in patients with disinhibition (p = 0.019) and hyposomnia (p = 0.043), and higher in patients with excessive worrying (p = 0.02) and verbal stereotypies/perseverations (p = 0.007). BMSE score was higher in patients who needed to do things immediately (p = 0.011), did excessive clock-watching (p = 0.019) and paid excessive attention to detail (p = 0.028), but it was much lower in patients with a loss of basic emotion (p = 0.002).
Table 4

Cognitive performance in relation to behavioral symptoms in PDD

Behavioral symptomsPDD
BMSEFAB
mean ± SDp valuemean ± SDp value
Loss of basic emotion
 Yes14.33±4.4570.002*5.17±3.6010.179
 No23.29±3.5839.57±6.465
Loss of embarrassment
 Yes14.33±4.0410.0934.00±3.4640.179
 No21.71±5.1939.00±6.134
Social avoidance
 Yes19.44±6.0230.3316.78±6.4760.23
 No21.55±5.3929.45±5.646
Neglect of hygiene
 Yes16.17±7.5740.0767.67±7.3120.718
 No22.50±3.3688.50±5.681
Loss of interest
 Yes19.00±6.0550.0817.77±6.4570.438
 No23.57±3.3599.14±5.49
Disinhibition
 Yes19.00±6.1910.4384.57±4.4290.019*
 No21.46±5.36410.23±5.96
Verbal stereotypies/perseverations
 Yes26.00±2.6460.07217.33±1.1550.007*
 No19.65±5.5116.65±4.974
Needs to do things immediately
 Yes28.50±0.7070.011*14.00±2.8280.211
 No19.72±5.2227.61±5.982
Exaggerated emotional display
 Yes24.00±5.00.35812.00±8.7180.416
 No20.00±5.6577.59±5.523
Irritability
 Yes20.91±5.4490.719.18±6.4930.766
 No20.22±6.1607.11±5.555
Aggression
 Yes22.00±4.1230.73511.40±6.2290.306
 No20.13±6.1057.20±5.784
Excessive worrying
 Yes23.63±3.0210.08211.88±5.2220.02*
 No18.58±6.1565.83±5.424
Seeks out social contact
 Yes22.63±2.560.3439.13±5.1390.384
 No19.25±6.7577.67±6.706

Asterisks denote significance. PDD, Parkinson's disease dementia; BMSE, Bengali Mental Status Examination; FAB, Frontal Assessment Battery.

Discussion

Executive dysfunction is common in bvFTD and subcortical dementias, due to disturbances of the dorsolateral prefrontal cortex and its subcortical connections. Patients with bvFTD often have associated parkinsonism and other motor features as well as incontinence, and patients with PDD exhibit behavioral changes like depression, apathy, anxiety, etc., sometimes making it difficult to make a diagnosis. In an attempt to find differentiating features between these 2 dementia syndromes, we explored the behavioral profiles of these patients. We recruited clinically diagnosed bvFTD patients regularly attending follow-up for >1 year at the Cognitive Clinic, and IPD patients regularly attending follow-up for >5 years at the MDC who had developed cognitive dysfunction that met the criteria for PDD. This process was to improve the diagnostic certainty of selected patients. Although the bvFTD patients were younger than the PDD patients, they were cognitively more impaired. Clinical manifestation of bvFTD is dominated by altered behavior and changes in social cognition. In our study, several behavioral symptoms showed very high sensitivity for bvFTD. The most sensitive features favoring bvFTD were: loss of basic and social emotions, selfishness, disinhibition, neglect of personal hygiene, loss of awareness of pain, loss of discrimination of food, wandering, pacing, utilization phenomena, failure to recognize objects, and mutism. The presence of these features makes a diagnosis of bvFTD more likely. Neuropsychiatric symptoms like suspiciousness, the false belief that people were in their home, and visual illusions/ hallucinations were more often observed in PDD patients, with significant discriminating value. These features clearly differentiate bvFTD and PDD patients. We found loss of basic emotion, selfishness, and social avoidance to be common in our bvFTD cohort and this helped in distinguishing bvFTD from PDD. Loss of embarrassment was also an important feature of social cognition that favored a diagnosis of bvFTD. Similar observations have been made by other researchers as well [4, 11, 20]. While IPD and PDD patients also exhibit features of apathy and a lack of empathy, these do not manifest often, appear late, and often mixed with depression [21, 22, 23, 24]. Another prominent discriminatory symptom of impaired social cognition was disinhibition (95 vs. 35%, p < 0.001, OR 35.29). Disinhibition has also been described in other studies [11, 20, 25]. Marked disinhibition is rare in PDD, and reported frequencies vary from 8 to 24% [24, 26]. The amygdala and orbitofrontal and medial prefrontal cortices (including the anterior cingulate cortex) are responsible for Theory of Mind (TofM). TofM is the ability of a person to understand what others are thinking and read their emotions. This is important for empathy, and a lack of it is an important feature of bvFTD. Neglect of personal hygiene was another discriminating feature observed in a relatively high proportion of the patients with bvFTD (85 vs. 30%, p = 0.001, OR 13.22). Other studies have also reported a high proportion (87–100%) of bvFTD patients with symptom [4, 11], and it is rare in patients with PDD where it is often mixed with depression or apathy [22, 25, 26, 27]. Early loss of insight was an important feature of bvFTD and many researchers have reported this, in 25–100% of patients [11, 28]; in PDD, however, it is relatively uncommon [22]. Loss of insight was observed in a large proportion of our bvFTD (95%) and PDD (80%) patients. That many of our PDD patients had loss of insight was possibly due to the manner the question was framed to elicit insightfulness. Rather than simply asking about their awareness of the disease, the question was whether the subject reacted to difficulties by becoming upset, distressed, or anxious, losing confidence, or withdrawing, and this might have elicited a more positive response from the PDD patients. Additionally, apathy (65%) and hidden depression might also have contributed in these patients. Exaggerated emotion, aggressiveness, and irritability were present in 25–70% of the bvFTD patients and 15–55% of the PDD patients. A similar excess of emotional responses has also been reported in other studies [11, 22, 24, 28, 29]. Like other studies [30, 31], altered sensory perception including the lack of pain sensation was found in a significantly high proportion of our bvFTD patients. Hyposmia was less frequent in the bvFTD (55%) patients than in the PDD (60%) patients. Hyposmia is a prominent nonmotor symptom, occurring in about 80–90% of PD patients [32, 33]. Although self-reporting, or reporting by the caregiver, may not provide a true account about smell perception, our observation of an abnormal perception of smell in a high proportion of the patients with bvFTD needs to be validated by proper evaluation in future studies. Abnormal eating and vegetative behaviors were observed more frequently in bvFTD than PDD, similar to the reports of other investigators [11, 13], although sweet-tongue and food faddism were not common in our bvFTD patients. A lack of taste discrimination, increased consumption of alcohol, and increased smoking clearly discriminated bvFTD from PDD. Altered eating behaviors are relatively uncommon in PDD. Several studies observed that PDD patients lose weight (20–30%), and that this is related to changed eating habits, bradykinesia, an altered perception of taste and smell, or the effect of medication [13, 24, 34]. Recent changes in patterns of smoking or drinking, or starting these habits, are behavioral features strongly suggesting bvFTD rather than any subcortical dementia. Eating continuously when food is present, food-cramming, seeking out food, stealing food from others' plates, etc. were observed in a higher proportion of our bvFTD patients than our PDD patients, but did not have discriminatory value. Wandering (70 vs. 20%, p = 0.004, OR 9.33) and pacing (50 vs. 10%, p = 0.014, OR 9) were reported more frequently in our bvFTD patients than in the PDD patients. These are also reported at similar frequencies in bvFTD by others [11, 31], but generally do not manifest in PDD. Although poorly understood, repetitive motor behavior is considered to be due to a disruption of coordinated function within the basal ganglia or corticostriatal structures [35]. Alteration of sexual behavior was also observed more commonly in our bvFTD patients, with 50% reported as having hyposexuality and 20% as having hypersexuality. A similar observation was made by Bathgate et al. [11] with hyposexuality in 58% and hypersexuality in 19%. One Indian study observed this behavior in 10% of their bvFTD patients [36]. Among our PDD patients, 30% reported hyposexuality and 10% reported hypersexuality. Hypersexuality has been reported in around 3.5% of IPD subjects as part of an impulse control disorder (ICD) [37]. Culturally, Indians are shy of expressing their sexual habits publicly. Moreover, hyposexuality is reported in many chronic diseases and may not be a feature specific to any disease. A change in sleep pattern was found in nearly equal frequency in both groups (80% in bvFTD and 75% in PDD), with no discriminatory value. Similar to in other neurodegenerative diseases, hypersomnolence is reported in 30–47% of patients with bvFTD [11, 38]. The literature suggests that 80% of IPD patients suffer from insomnia [39], while 50% experience excessive daytime sleepiness [40], and 30–90% exhibit REM sleep behavior disorder [41]. Although repetitive and compulsive behaviors were more commonly found in our bvFTD cohort, we did not find them to discriminate bvFTD from PDD. Mendez and Perryman [28] observed perseverative and stereotyped behavior including compulsive-like acts in 45.3% of FTD patients at presentation, and this increased to 88.7% at the 2-year follow-up. ICDs are observed in IPD patients receiving dopa-agonists and these include compulsive gambling, buying, sexual, and eating behaviors, punding (stereotyped, repetitive, purposeless behaviors), and hobbyism (e.g., compulsive internet use, artistic endeavors, and writing) [42]. ICDs result from a dysregulation of the mesocorticolimbic dopamine system and alterations in the opiate and serotonin systems [42]. Around 13.6% of IPD patients report ICDs while on dopa-agonists [43]. However, there are limited data about this characteristic behavior in both PDD and bvFTD patients. Chiu et al. [24] showed that 16% of PDD patients had repetitive behaviors. Another compulsive behavior observed in IPD patients receiving short-acting potent dopaminergic drugs like L-dopa is dopamine dysregulation syndrome, which manifests as compulsive medication overuse [44]. Environmental dependency-related behaviors were observed in both groups. Among these, utilization behavior was significantly higher in bvFTD, observed in 35% of the patients, but not in any of the PDD patients (p = 0.008, OR 22.78), suggesting this to be a strong discriminating feature. This is a very interesting clinical sign observed in >75% of bvFTD patients in an Indian study [45], but others have reported that this behavior occurs less frequently [5, 11, 15, 28]. The questionnaires also tried to assess cognition and spatial function; 70% of the bvFTD patients and 60% of the PDD patients responded that they had problems with cognition and spatial dysfunction. What is intriguing is that many of our bvFTD caregivers responded positively to the questions relating to disturbance in visuospatial and perceptual functions. The symptoms related to visuospatial-perceptual function was detected in 65% of bvFTD and 40% of PDD patients. As this was a questionnaire-based assessment and our bvFTD cohort were more demented than the PDD patients, the result might not be a true indication of the deficits in this sphere of cognition and would require a more detailed evaluation. Interestingly, mutism was found to be significantly more common in bvFTD and is therefore a discriminatory feature. Psychotic symptoms were more prominent in PDD (80%) than in bvFTD (50%). Delusional behaviors with suspiciousness, the belief that someone is in the home, and visual illusions/hallucinations were found to be significantly more frequent in PDD patients than in bvFTD patients, making these notable discriminatory features. Psychotic symptoms, particularly visual hallucinations, are very characteristic of PDD and dementia with Lewy bodies, primarily because of the impact on areas of visual association. Delusions and hallucinations have been reported in PD, in 30–40% and 45–65% of patients, respectively [22, 24]. These studies also suggest that visual hallucinations in PD predict the development of dementia. Delusions and hallucinations are relatively uncommon in bvFTD, except in some patients such as those with bvFTD due to the C9orf72 mutation [46]. While correlating cognitive performance with behavioral symptoms, we observed a trend. In the PDD group, although not statistically significant, patients with some of the behavioral symptoms tended to have a lower mean FAB score (<8; Table 4). These symptoms were: loss of basic emotion, loss of embarrassment, social avoidance, neglect of hygiene, and loss of interest, which might be considered as “negative” symptoms. On the other hand, patients with some of the other symptoms had higher mean FAB scores (>8). These symptoms were: verbal stereotypies/perseverations, excessive worrying, the need to do things immediately, exaggerated emotional display, irritability, aggression, and seeking out social contact, which might be considered as “positive” symptoms. This indicates that, in PDD, more advanced disease with lower FAB scores might placate the expressive or “positive” behavioral symptoms to some extent. However, it was not possible to generalize, as the FAB scores were significantly lower in the patients displaying disinhibition. Moreover, it was difficult to comment on the bvFTD patients, as most of them had very low FAB scores. Hence, these findings should be evaluated in larger studies to arrive at an accurate conclusion. Dementia with a predominantly frontal dysexecutive pattern may be seen in both cortical (e.g., bvFTD) and subcortical (e.g., PDD) disorders. Behavioral symptoms form an important part of such dementias, and our study suggests that some of these behaviors have a discriminatory value for differentiating between these disorders. We found that several behavioral symptoms increased the odds for bvFTD versus PDD. In a previous study, Moretti et al. [47] observed prominent abnormalities in personality and social conduct with a significant loss of insight in frontal-lobe dementia when compared to subcortical vascular dementia. Hence, although larger-scale comparative studies are required, it can be inferred that behavioral symptoms help to distinguish cortical dementia with frontal-lobe dysfunction from subcortical dementia. This study has a few limitations. The small sample size was a major limitation which could have impacted the power of the study. As features of degenerative disease evolve over time, a cross-sectional assessment does not exactly depict the full spectrum of behavior of these patients. Moreover, the lack of pathological confirmation of patients was another limitation. However, we carefully chose our patients after a long follow-up before recruiting them, so as to ensure a better diagnosis. The systematic analysis of symptoms of behavioral changes was the strength of the study. To conclude, we observed significant differences in behavioral symptoms between bvFTD and PDD patients, with several symptoms showing higher frequency in bvFTD. It may be that the degeneration of the prefrontal cortex is mostly responsible for frontal behavioral symptoms, and that these are relatively uncommon in subcortical diseases despite having rich to-and-fro connections between the two.

Statement of Ethics

This research work was conducted ethically in accordance with the World Medical Association Declaration of Helsinki, after getting clearance from the Institutional Ethics Committee of the IPGME&R, Kolkata, India (No. Inst/IEC/2015/287 dated April 6, 2015). Written informed consent was obtained from patients and their caregivers or legally acceptable representatives before recruiting them for the study.

Conflict of Interest Statement

Authors declare there were no conflicts of interest.

Author Contributions

All listed authors contributed intellectually for the study and manuscript preparation. D.S.: data collection, tabulation, and statistical analysis; A.M.: statistical analysis, and manuscript preparation; A.R.: monitoring and supervision of data collection, and manuscript preparation; A.B.: conceptualization of study and methodology, supervision of data collection, and drafting of manuscript.
  43 in total

1.  Pain and motor complications in Parkinson's disease.

Authors:  M Tinazzi; C Del Vesco; E Fincati; S Ottaviani; N Smania; G Moretto; A Fiaschi; D Martino; G Defazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

Review 2.  Impulse Control and Related Disorders in Parkinson's Disease.

Authors:  Daniel Weintraub; Daniel O Claassen
Journal:  Int Rev Neurobiol       Date:  2017-06-01       Impact factor: 3.230

3.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

4.  Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia.

Authors:  D Bathgate; J S Snowden; A Varma; A Blackshaw; D Neary
Journal:  Acta Neurol Scand       Date:  2001-06       Impact factor: 3.209

Review 5.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

6.  Environmental dependency behaviours in frontotemporal dementia: have we been underrating them?

Authors:  Amitabha Ghosh; Aparna Dutt; Pallavi Bhargava; Julie Snowden
Journal:  J Neurol       Date:  2012-10-30       Impact factor: 4.849

7.  Inappropriate crying and laughing in Parkinson disease and movement disorders.

Authors:  Mustafa S Siddiqui; Hubert H Fernandez; Cynthia W Garvan; Lindsey Kirsch-Darrow; Dawn Bowers; Ramon L Rodriguez; Charles E Jacobson; Christian Rosado; Swetha Vaidyanathan; Kelly D Foote; Michael S Okun
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132

8.  Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members.

Authors:  Emma M Devenney; Rebekah M Ahmed; Glenda Halliday; Olivier Piguet; Matthew C Kiernan; John R Hodges
Journal:  Neurology       Date:  2018-09-26       Impact factor: 9.910

Review 9.  Hypersexuality in Parkinson's Disease: Systematic Review and Report of 7 New Cases.

Authors:  David Codling; Philip Shaw; Anthony S David
Journal:  Mov Disord Clin Pract       Date:  2015-04-30

10.  Using the revised diagnostic criteria for frontotemporal dementia in India: evidence of an advanced and florid disease.

Authors:  Amitabha Ghosh; Aparna Dutt; Madhura Ghosh; Pallavi Bhargava; Sulakshana Rao
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.